Secukinumab (Cosentyx®) Effectiveness in Axial Spondyloarthritis and Psoriatic Arthritis Patients Using Artificial Intelligence (SpAINET): Spanish Multicenter, Retrospective, Real World Evidence Study
Clinical trial NCT05677542 · COMPLETED
Trial details
- NCT number
- NCT05677542
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-06-02
- Primary completion
- 2021-12-31
- Enrollment
- 758
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.